Skip to main content
Premium Trial:

Request an Annual Quote

Ibidi, JPK Instruments, Evident Technologies


Ibidi has launched ibiTreat, a new surface modification for improved cell adhesion on u-Slides, Ibidi’s microscopy carriers, the company said last week.

Ibidi’s u-Slides allow cell culturing and high-resolution microscopy using the same slide, the company said. The ibiTreat improves microscopic analysis of living and fixed cells, and allows analysis of endothelial cells even under perfusion conditions, the company said.

JPK Instruments has introduced the CellHesion Development Kit, a new product for the study of cellular adhesion phenomena, the company said last week.

According to the company, the CellHesion kit “uses the high sensitivity of a nano-mechanical sensor to determine the actual force of single cell adhesion and the ‘work of removal’ that is necessary to separate cells from specific substrates or other cells. The product is available as an add-on to the NanoWizard BioAFM, and can be combined with its nano-imaging, measuring, and manipulation functions.

Evident Technologies last week introduced a second-generation Type 2 EviTag luminescent label, the company said.

The Type 2 EviTag has a proprietary natural coating that provides increased flexibility, easier use, wider applications, and possible reduced testing costs in biological assays and other types of life science research, the company said.

Evident Tech also said that the new tags’ properties make them more suitable for fluorescent resonance energy transfer work, live animal or in vivo imaging, and molecular targeting.

The tags are available in seven colors from Lake Placid Blue (490 nanometers) to Maple-Red Orange (620 nanometers), with several conjugation-ready surfaces.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.